How to Value a Mobile MRI Company in 2026

Mobile MRI companies occupy an unusual niche in healthcare services. You're running what is essentially a fleet logistics business wrapped around $1-3M medical devices, serving hospitals and clinics that need imaging capacity but can't justify or accommodate a fixed installation. The valuation dynamics are unlike almost any other healthcare business I work with.

The market has matured significantly. Alliance HealthCare Services was taken private by THL Partners, Shared Medical Services and other mid-size operators have been acquired, and PE-backed platforms are actively rolling up independent operators. If you own a mobile MRI company with 3+ units and established route contracts, you have a business that specific buyers want. Understanding what drives your valuation is the difference between an average exit and a strong one.

The Multiple Range and What Drives It

Mobile MRI companies typically trade at 5-8x EBITDA, with the range determined primarily by contract quality, unit count, and equipment age. That's a wide spread, and I want to be specific about what puts you at 5x versus 8x.

At 5-6x EBITDA, you're looking at companies with 2-4 units, a mix of contracted and per-diem routes, equipment approaching end-of-useful-life, and meaningful owner involvement in scheduling and client management. These are solid businesses, but the buyer sees operational risk and near-term capital expenditure requirements.

At 7-8x EBITDA, the profile shifts: 6+ units, predominantly multi-year hospital contracts, newer equipment (installed within the last 5-7 years), employed technologists rather than contract staffing, and management that operates independently of the owner. These companies look like platforms a PE firm can build on.

Unit Economics: The Core of Mobile MRI Valuation

Every buyer I've worked with in this space starts with per-unit economics. They want to know what each MRI system generates and costs on a standalone basis.

Revenue per unit varies enormously depending on scan volume and payer mix. A 1.5T mobile MRI running 4-5 days per week at a community hospital might generate $600K-$900K annually. A 3T system serving an orthopedic group or academic center can push past $1.2M. The spread comes down to scan volume (8-12 scans per day is healthy) and whether you're billing directly or providing the unit on a per-diem or time-share basis.

Equipment cost and remaining useful life is the single largest variable in the business. A new wide-bore 1.5T MRI system costs $1.5-2.5M. A 3T system runs $2-3M. The trailer and power systems add another $200-400K. Buyers calculate remaining useful life aggressively — MRI systems have a practical useful life of 10-12 years before maintenance costs escalate and image quality falls behind current standards. A fleet with an average age of 4 years is worth materially more than one averaging 8 years, because the buyer isn't staring at $5-10M in near-term replacement capex.

Maintenance contracts and coil inventory are where diligence gets granular. MRI maintenance contracts (OEM or third-party) run $100-200K per unit annually. Buyers need to see these contracts, their terms, what's covered, and the claims history. RF coils degrade over time and cost $15-60K each to replace. Sellers who keep detailed coil inventory and maintenance logs get better terms.

Route Contracts: The Value Driver Buyers Pay Premium For

The quality and duration of your hospital and clinic contracts is the single most important driver of where you fall in the multiple range. Recurring, contracted revenue is always worth more than spot or per-diem revenue, and in mobile imaging the difference is dramatic.

Multi-year contracts with volume minimums are gold. A 3-5 year agreement with a hospital system that guarantees 4 days per week of MRI access, with automatic renewals, gives a buyer predictable cash flow they can lever against. I've seen companies with 80%+ contracted revenue get full-turn premiums over comparable companies running mostly per-diem routes.

Per-diem and short-term arrangements — where a hospital calls you when their fixed MRI is down or when volume spikes — are lower quality revenue. They're often higher-margin on a per-scan basis, but they're unpredictable and don't provide the base a buyer needs to underwrite a leveraged acquisition.

Contract transferability is a due diligence flashpoint. Many hospital contracts contain change-of-control provisions or consent requirements. If your top three contracts require hospital board approval to transfer, that's a risk buyers will price into their offer or address through earnout structures.

Technologist Staffing: The Hidden Constraint

MRI technologist staffing has become one of the most acute pain points in healthcare, and it directly impacts mobile imaging valuations.

Companies that employ their own full-time MRI technologists are worth more than those relying on contract or agency staffing. Full-time techs cost less ($65-90K salary plus benefits versus $80-120K equivalent for agency techs), provide more consistent image quality, and build relationships with hospital staff that reinforce your contracts.

Buyers will ask about technologist tenure, credentials (ARRT certification, state licenses), and whether you have backup coverage. A company where one tech calls in sick and a hospital route goes unserved has a staffing problem that depresses value. A company with a deep enough bench to cover absences without scrambling demonstrates operational maturity.

The retention metrics matter here. If you're turning over 30-40% of your technologists annually, buyers see a management problem that will persist after closing.

Regulatory and Compliance Considerations

Mobile imaging companies face a regulatory layer that general healthcare services businesses don't. State licensure requirements for mobile units vary significantly. Some states require separate facility licenses for each mobile unit. ACR accreditation is effectively mandatory for hospital contracts. Radiation safety compliance, DOT vehicle requirements for the trailer rigs, and CMS Conditions for Coverage all factor into due diligence.

Buyers view a clean compliance history as expected, not as a value-add. But compliance deficiencies — a lapsed ACR accreditation, outstanding DOT violations, or incomplete radiation safety logs — can delay or kill a transaction. Have your compliance house in order well before going to market.

Who Buys Mobile MRI Companies

Three buyer categories dominate this market.

PE-backed imaging platforms are the most active acquirers. They're building regional or national mobile imaging networks and want your route density, your contracts, and your technologist workforce. These buyers pay 6-8x EBITDA for bolt-on acquisitions and can move quickly.

Hospital systems integrating mobile imaging. Some health systems that are your largest customers will acquire your company to bring the service in-house. These deals often happen when a contract renewal triggers a make-versus-buy analysis internally.

Independent operators looking to grow. Smaller deals (2-4 units) may sell to another independent operator expanding into your geography. These buyers typically pay 4-6x and structure significant portions as seller financing.

The Bottom Line

Mobile MRI company valuation comes down to a straightforward equation: contracted revenue predictability times fleet quality divided by near-term capital requirements. If you have long-term hospital contracts covering 80%+ of revenue, equipment averaging under 6 years old, employed technologists with low turnover, and clean compliance records, you're positioned at the upper end of the 5-8x EBITDA range. Every weakness in that profile — aging equipment, per-diem-heavy revenue, agency-dependent staffing — pulls you toward the lower end. The buyers in this space are sophisticated and they know exactly what they're underwriting.